Technical Analysis for INZY - Inozyme Pharma, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Up | Up |
| Historical INZY trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Reversal New Highs Setup | Bullish Swing Setup | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Wide Bands | Range Expansion | 5.48% | |
| Overbought Stochastic | Strength | 5.48% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Upper Bollinger Band Resistance | 1 day ago | |
| Rose Above Upper Bollinger Band | 1 day ago | |
| Up 5% | 1 day ago | |
| Up 10% | 1 day ago | |
| Up 1 ATR | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as in the early stages of development for calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Pharmaceutical Industry Disease Pharmacy Molecular Biology Specialty Drugs Genetic Disease Genetic Diseases Rare Genetic Disease Rare Genetic Diseases Recombinant Dna
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Pharmaceutical Industry Disease Pharmacy Molecular Biology Specialty Drugs Genetic Disease Genetic Diseases Rare Genetic Disease Rare Genetic Diseases Recombinant Dna
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 31.6499 |
| 52 Week Low | 16.1 |
| Average Volume | 39,617 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 24.75 |
| 20-Day Moving Average | 24.61 |
| 10-Day Moving Average | 25.97 |
| Average True Range | 1.93 |
| ADX | 15.44 |
| +DI | 30.18 |
| -DI | 16.82 |
| Chandelier Exit (Long, 3 ATRs ) | 23.67 |
| Chandelier Exit (Short, 3 ATRs ) | 25.19 |
| Upper Bollinger Band | 28.78 |
| Lower Bollinger Band | 20.43 |
| Percent B (%b) | 0.89 |
| BandWidth | 33.95 |
| MACD Line | 0.77 |
| MACD Signal Line | 0.36 |
| MACD Histogram | 0.4074 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 34.34 | ||||
| Resistance 3 (R3) | 34.14 | 31.80 | 33.26 | ||
| Resistance 2 (R2) | 31.80 | 30.16 | 31.90 | 32.90 | |
| Resistance 1 (R1) | 29.85 | 29.15 | 30.83 | 30.05 | 32.55 |
| Pivot Point | 27.51 | 27.51 | 28.00 | 27.61 | 27.51 |
| Support 1 (S1) | 25.56 | 25.87 | 26.54 | 25.76 | 23.25 |
| Support 2 (S2) | 23.22 | 24.86 | 23.32 | 22.90 | |
| Support 3 (S3) | 21.27 | 23.22 | 22.54 | ||
| Support 4 (S4) | 21.47 |
